Kirchheiner, J.

patient dosing coumarin study warfarin trial cyp 2c therapy algorithm anticoagulation coumarin derivatives vkorc requirement pharmacogenetic derivative eu-pact randomized outcome acenocoumarol genotype-guided group loading polymorphism anticoagulant therapy dose requirements anticoagulation therapy treatment monitoring vkorc 1 genes genotype hemorrhage anticoagulant dosing algorithms report range science pharmacol university loading dose algorithm monitoring dose algorithm report van schie safety factor vkorc 1 phenprocoumon future netherland event utrecht 3  months center warfarin dose maintenance number interindividual variability genotype-guided dosing ƒƒ time eu-pact trial wadeliu –effectivenes blood information regimen van meegen e vkorc 1 gene design european anticoagulation response control value european pharmacogenetics cost –effectiveness initiation dosing regimen genotyping variability alcohol practice dose requirement month